[1]Li C,Xia G,Jianqing Z,et al.Serum differential protein identification of Xinjiang Kazakh esophageal cancer patients based on the two-dimensional liquid-phase chromatography and LTQ MS[J].Molecular Biology Reports,2014,41(5):2893-2905.
[2]Bray F,Ferlay J,Soerjomataram I,et al.Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA:A Cancer Journal for Clinicians,2018,68(6):394-424.
[3]Li D,Song G,Liang D,et al.Cancer survival in Cixian of China,2003-2013:A population-based study[J].Cancer Medicine,2018,7(4):1537-1545.
[4]Wu CH,Hsu CL,Lu PC,et al.Identification of lncRNA functions in lung cancer based on associated protein-protein interaction modules[J].Scientific Reports,2016(6):35939.
[5]Sun K,Jia Z,Duan R,et al.Long non-coding RNA XIST regulates miR-106b-5p/P21 axis to suppress tumor progression in renal cell carcinoma[J].Biochemical and Biophysical Research Communications,2019,510(3):416-420.
[6]Yan Y,Li S,Wang S,et al.Long noncoding RNA HAND2-AS1 inhibits cancer cell proliferation,migration,and invasion in esophagus squamous cell carcinoma by regulating microRNA-21[J].Journal of Cellular Biochemistry,2018,120(6):9564-9571.
[7]Chen DL,Ju HQ,Lu YX,et al.Long non-coding RNA XIST regulates gastric cancer progression by acting as a molecular sponge of miR-101 to modulate EZH2 expression[J].Journal of Experimental & Clinical Cancer Research:CR,2016,35(1):142.
[8]Liu JL,Zhang WQ,Zhao M,et al.Upregulation of long noncoding RNA XIST is associated with poor prognosis in human cancers[J].Journal of Cellular Physiology,2019,234(5):6594-6600.
[9]Fang J,Sun CC,Gong C.Long noncoding RNA XIST acts as an oncogene in non-small cell lung cancer by epigenetically repressing KLF2 expression[J].Biochemical and Biophysical Research Communications,2016,478(2):811-817.
[10]Liu H,Deng H,Zhao Y,et al.LncRNA XIST/miR-34a axis modulates the cell proliferation and tumor growth of thyroid cancer through MET-PI3K-AKT signaling[J].Journal of Experimental & Clinical Cancer Research:CR,2018,37(1):279.
[11]Chen LP,Wang H,Zhang Y,et al.Robust analysis of novel mRNA-lncRNA cross talk based on ceRNA hypothesis uncovers carcinogenic mechanism and promotes diagnostic accuracy in esophageal cancer[J].Cancer Management and Research,2019(11):347-358.
[12]Ren C,Chen H,Han C,et al.miR-486-5p expression pattern in esophageal squamous cell carcinoma,gastric cancer and its prognostic value[J].Oncotarget,2016,7(13):15840-15853.
[13]He Y,Liu J,Wang Y,et al.Role of miR-486-5p in regulating renal cell carcinoma cell proliferation and apoptosis via TGF-beta-activated kinase 1[J].Journal of Cellular Biochemistry,2019,120(3):2954-2963.
[14]Yu S,Geng S,Hu Y.miR-486-5p inhibits cell proliferation and invasion through repressing GAB2 in non-small cell lung cancer[J].Oncology Letters,2018,16(3):3525-3530.
[15]Gao ZJ,Yuan WD,Yuan JQ,et al.miR-486-5p functions as an oncogene by targeting PTEN in non-small cell lung cancer[J].Pathology,Research and Practice,2018,214(5):700-705.